BON.F 24.05 (+1.05%)
FR0000061129Drug ManufacturersDrug Manufacturers - Specialty & Generic

Boiron (BON.F) Competitor Comparison

We are evaluating the key criteria listed to compare Boiron (BON.F) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Performance 5 years - BON.F ranking 0 / 54

These are the competitors of Boiron in the industry Drug Manufacturers - Specialty & Generic ranked by performance 5 years
1. Harrow Health HROW
513.78
2. Regencell Bioscience Holdings RGC
410.42
3. Evolus EOLS
216.23
4. Amneal Pharmaceuticals AMRX
116.67
5. ANI Pharmaceuticals ANIP
88.26
6. Teva Pharmaceutical Industries TEVA
62.92
7. Organogenesis Holdings ORGO
53.04
8. Collegium Pharmaceutical COLL
50.6
9. Amphastar Pharmaceuticals AMPH
45.66
10. Supernus Pharmaceuticals SUPN
42.6
11. Kolinpharma KIP.MI
42.45
12. Vifor Pharma G2AB.F
39.09
13. PetIQ PETQ
23.72
14. Alimera Sciences ALIM
23.11
15. Zoetis ZTS
22.86
16. Catalent CTLT
19.28
17. Cumberland Pharmaceuticals CPIX
13.07
18. Linc LNC
-1.14
19. Avadel Pharmaceuticals AVDL
-5.95
20. Green Thumb Industries R9U2.F
-6.23
21. Kamada KMDA
-9.14
22. Alvotech ALVO
-13.47
23. Phibro Animal Health PAHC
-19.17
24. Journey Medical DERM
-19.2
25. Pacira BioSciences PCRX
-31.23
26. Taro Pharmaceutical Industries TARO
-50.4
27. Perrigo PRGO
-51.36
28. ProPhase Labs PRPH
-56.67
29. Elanco Animal Health ELAN
-60.39
30. Cronos Group CRON
-67.26
31. Bausch Health Companies BHC
-68.02
32. Alpha Teknova TKNO
-68.53
33. Theratechnologies THTX
-69.76
34. Neoleukin Therapeutics NLTX
-70.42
35. Embecta EMBC
-73.48
36. Curaleaf Holdings CURLF
-78.18
37. Jupiter Wellness JUPW
-80
38. Zynerba Pharmaceuticals ZYNE
-82.07
39. Societal CDMO SCTL
-85.58
40. Ayr Wellness 3KJB.F
-86.37
41. SCYNEXIS SCYX
-86.49
42. Solid Biosciences SLDB
-87.51
43. Ascend Wellness Holdings AAWH
-89.54
44. Ironwood Pharmaceuticals IRWD
-90.31
45. OptiNose OPTN
-90.87
46. Procaps Group PROC
-91.37
47. Emergent BioSolutions EBS
-93.45
48. Tilray Brands TLRY
-94.44
49. Universe Pharmaceuticals UPC
-98.29
50. Relmada Therapeutics RLMD
-98.35
51. Eagle Pharmaceuticals EGRX
-98.48
52. Biofrontera BFRI
-98.78
53. Flora Growth FLGC
-99.09
54. Clever Leaves Holdings CLVR
-100

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.